A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing
- Ben Mulhearn
- , Danyang Li
- , Fionnuala McMorrow
- , Hui Lu
- , Neil J. McHugh
- , Sarah L. Tansley
- Royal National Hospital for Rheumatic Diseases
Research output: Contribution to journal › Article › peer-review
23
Link opens in a new tab
Citations
(SciVal)
164
Downloads
(Pure)